128 related articles for article (PubMed ID: 2372506)
1. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Ribera JM; Feliu E; Montserrat E; Grañena A; Vives-Corrons JL; Rozman C
Br J Haematol; 1990 Jun; 75(2):202-7. PubMed ID: 2372506
[TBL] [Abstract][Full Text] [Related]
2. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
3. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance.
Cantù-Rajnoldi A; Putti C; Saitta M; Granchi D; Foà R; Schirò R; Castagni M; Valeggio C; Jankovic M; Miniero R
Br J Haematol; 1991 Sep; 79(1):40-3. PubMed ID: 1911387
[TBL] [Abstract][Full Text] [Related]
7. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
8. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification.
Quintanilla-Martínez L; Zukerberg LR; Ferry JA; Harris NL
Am J Clin Pathol; 1995 Oct; 104(4):431-43. PubMed ID: 7572794
[TBL] [Abstract][Full Text] [Related]
9. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Iwamoto S; Deguchi T; Ohta H; Kiyokawa N; Tsurusawa M; Yamada T; Takase K; Fujimoto J; Hanada R; Hori H; Horibe K; Komada Y
Int J Hematol; 2011 Aug; 94(2):185-192. PubMed ID: 21800074
[TBL] [Abstract][Full Text] [Related]
12. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
[TBL] [Abstract][Full Text] [Related]
13. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
17. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis.
Hanson CA; Abaza M; Sheldon S; Ross CW; Schnitzer B; Stoolman LM
Br J Haematol; 1993 May; 84(1):49-60. PubMed ID: 7687860
[TBL] [Abstract][Full Text] [Related]
18. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
19. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
20. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]